Shares of Nikola Corporation NKLA fell sharply in Monday's session after the company announced it entered into a securities purchase agreement and filed for a mixed shelf offering.
Nikola shares dipped 10.4% to $7.28 on Monday.
Here are some other stocks moving in today’s mid-day session.
Gainers
- Alzamend Neuro, Inc. ALZN shares jumped 262% to $7.37 after the company announced that it is partnering with Massachusetts General Hospital as its contract research organization to conduct first of its kind Phase II clinical study of AL001 for treatment of patients with PTSD.
- Virax Biolabs Group Limited VRAX gained 152% to $5.37. Shares of vaccine and mpox-related stocks traded higher on continued strength after the WHO last week declared the virus a global health emergency.
- Applied DNA Sciences, Inc. APDN shares climbed 116% to $1.6903 after jumping 78% on Friday.
- Sonder Holdings Inc. SOND rose 66% to $4.36 after the company announced a long-term licensing agreement with Marriott. Additionally, the company secured $146 million in additional liquidity.
- Tonix Pharmaceuticals Holding Corp. TNXP gained 60% to $0.7158 following second-quarter results.
- GeoVax Labs, Inc. GOVX gained 36% to $9.60 adding to gains of more than 225% over the past week.
- fuboTV Inc. FUBO rose 29% to $1.9700 after a judge temporarily blocked the Fox-Disney-Warner streaming venture, Venu.
- Telomir Pharmaceuticals, Inc. TELO rose 28.2% to $5.11.
- ALT5 Sigma Corporation ALTS gained 27% to $2.88.
- Terran Orbital Corporation LLAP rose 26% to $0.3177. Terran Orbital’s Tyvak was awarded $254 million Prototype agreement for Tranche 2 Transport Layer (T2TL) Gamma for Space Development Agency.
- Maxeon Solar Technologies, Ltd. MAXN gained 25% to $0.1450.
- Sidus Space, Inc. SIDU rose 22% to $3.21.
- Foghorn Therapeutics Inc. FHTX surged 20.9% to $7.57. Evercore ISI Group analyst Gavin Clark-Gartner initiated coverage on Foghorn Therapeutics with an Outperform rating and announced a price target of $20.
- ZIM Integrated Shipping Services Ltd. ZIM gained 19.6% to $22.80 after the company reported better-than-expected second-quarter financial results and raised its FY24 guidance.
- MultiSensor AI Holdings, Inc. MSAI rose 17% to $2.10.
- Xperi Inc. XPER gained 13.7% to $8.59 after the company announced that it entered into an agreement with Amazon.com services for the sale of nearly all assets and some liabilities for $80 million.
- Inozyme Pharma, Inc. INZY climbed 12% to $5.13.
- TG Therapeutics, Inc. TGTX gained 11.6% to $24.66.
- Clover Health Investments, Corp. CLOV gained 11.5% to $3.1550.
- Valneva SE VALN rose 10.7% to $8.27.
- Digital Turbine, Inc. APPS gained 8% to $3.940.
- e.l.f. Beauty, Inc. ELF jumped 5.2% to $167.50.
Losers
- Liquidia Corporation LQDA shares tumbled 39% to $8.63. The company announced that the FDA granted tentative approval of YUTREPIA inhalation powder to treat adults with pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.
- Theriva Biologics, Inc. TOVX shares dipped 30% to $0.1411 after the company announced a 1-for-25 reverse stock split.
- Cingulate Inc. CING dipped 28.8% to $12.59 after the company increased the maximum offering price for common stock under its sales agreement from $8.47 million to $11.33 million.
- Seelos Therapeutics, Inc. SEEL fell 28.2% to $0.3090.
- GD Culture Group Limited GDC fell 25% to $1.51.
- Yunji Inc. YJ declined 20.7% to $0.5950. Yunji will release its second quarter financial results before the market opens on Friday, Aug. 23.
- Genius Group Limited (NYSE GNS) declined 19.8% to $1.0980.
- Greenlane Holdings, Inc. GNLN fell 16.5% to $8.85.
- Faraday Future Intelligent Electric Inc. FFIE declined 14% to $4.42.
- Graphjet Technology GTI fell 9.4% to $1.9737.
- Zevra Therapeutics, Inc. ZVRA declined 8.4% to $6.74.
- CompX International Inc. CIX fell 7.7% to $30.00.
- ImmunityBio, Inc. IBRX declined 6.4% to $3.7550.
- Sweetgreen, Inc. SG fell 6.4% to $34.85 after Piper Sandler downgraded the stock from Overweight to Neutral and announced a $39 price target.
- HP Inc. HPQ fell 3.6% to $34.61 after Morgan Stanley downgraded the stock from Overweight to Equal-Weight.
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in